Literature DB >> 9326292

Energetic dysfunction in quinolinic acid-lesioned rat striatum.

Y M Bordelon1, M F Chesselet, D Nelson, F Welsh, M Erecińska.   

Abstract

Impairment of mitochondrial energy metabolism may contribute to the selective neuronal degeneration observed in Huntington's disease and other neurodegenerative disorders. Intrastriatal injection of the excitotoxin, quinolinic acid, produces a pattern of neuronal death similar to that seen in Huntington's disease. However, little is known about the effects of quinolinic acid on striatal energetics. In the present work, time-dependent changes in energy metabolism caused by injection of quinolinic acid into rat striatum were examined. Oxygen consumption by free and synaptic mitochondria was quantified and correlated with the concentrations of nucleotides and amino acids at different times after injection. Compared with saline-treated controls, a decrease in ADP-stimulated (state 3) to basal (state 4) oxygen consumption (respiratory control ratio) by free mitochondria was apparent in quinolinic acid-injected striata as early as 6 h after treatment. No significant changes were seen in nucleotide concentrations at this time. By 12 h after injection, the decline in the respiratory control ratio was more pronounced (45%), and reductions in ATP, NAD, aspartate, and glutamate (30-60%) were also observed. These results show that injection of quinolinic acid in vivo produces progressive mitochondrial dysfunction, which may be a common and critical event in the cell death cascade initiated in Huntington's disease and in animal models of this neurodegenerative disorder. The indicators of mitochondrial function examined in this study, therefore, may be useful in evaluating the efficacy of neuroprotective agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326292     DOI: 10.1046/j.1471-4159.1997.69041629.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Huntington's disease and mitochondrial alterations: emphasis on experimental models.

Authors:  Verónica Pérez-De la Cruz; Paul Carrillo-Mora; Abel Santamaría
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.

Authors:  Chaitali Ghosh; Nicola Marchi; Mohammed Hossain; Peter Rasmussen; Andreas V Alexopoulos; Jorge Gonzalez-Martinez; Hu Yang; Damir Janigro
Journal:  Neurobiol Dis       Date:  2012-03-09       Impact factor: 5.996

Review 3.  Effects of sulforaphane on brain mitochondria: mechanistic view and future directions.

Authors:  Fernanda Rafaela Jardim; Fhelipe Jolner Souza de Almeida; Matheus Dargesso Luckachaki; Marcos Roberto de Oliveira
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

4.  Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-Induced Toxicity in Rat Striatal Slices.

Authors:  Fernanda Silva Ferreira; Helena Biasibetti-Brendler; Paula Pierozan; Felipe Schmitz; Carolina Gessinger Bertó; Caroline Acauan Prezzi; Vanusa Manfredini; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2018-03-21       Impact factor: 5.590

Review 5.  Involvement of quinolinic acid in AIDS dementia complex.

Authors:  Gilles J Guillemin; Stephen J Kerr; Bruce J Brew
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Quinolinic Acid-Induced Huntington Disease-Like Symptoms Mitigated by Potent Free Radical Scavenger Edaravone-a Pilot Study on Neurobehavioral, Biochemical, and Histological Approach in Male Wistar Rats.

Authors:  Thangarajan Sumathi; Aishwariya Vedagiri; Surekha Ramachandran; Bhagyalakshmi Purushothaman
Journal:  J Mol Neurosci       Date:  2018-10-03       Impact factor: 3.444

Review 7.  Potassium channel dysfunction in neurons and astrocytes in Huntington's disease.

Authors:  Xiao Zhang; Jie-Qing Wan; Xiao-Ping Tong
Journal:  CNS Neurosci Ther       Date:  2018-01-27       Impact factor: 5.243

8.  Neurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice.

Authors:  Leandro Ceotto Freitas Lima; Soraya Wilke Saliba; João Marcus Oliveira Andrade; Maria Luisa Cunha; Puebla Cassini-Vieira; John David Feltenberger; Lucíola Silva Barcelos; André Luiz Sena Guimarães; Alfredo Mauricio Batista de-Paula; Antônio Carlos Pinheiro de Oliveira; Sérgio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2016-05-16       Impact factor: 5.590

9.  Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.

Authors:  Bianca Seminotti; Alexandre Umpierrez Amaral; Rafael Teixeira Ribeiro; Marília Danyelle Nunes Rodrigues; Ana Laura Colín-González; Guilhian Leipnitz; Abel Santamaría; Moacir Wajner
Journal:  Mol Neurobiol       Date:  2015-11-25       Impact factor: 5.590

Review 10.  The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease.

Authors:  Marta Amaral; Tiago F Outeiro; Nigel S Scrutton; Flaviano Giorgini
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.